Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease
- PMID: 28549949
- DOI: 10.1016/j.jconrel.2017.05.019
Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease
Abstract
In this modern era, with the help of various advanced technologies, medical science has overcome most of the health-related issues successfully. Though, some diseases still remain unresolved due to various physiological barriers. One such condition is Alzheimer; a neurodegenerative disorder characterized by progressive memory impairment, behavioral abnormalities, mood swing and disturbed routine activities of the person suffering from. It is well known to all that the brain is entirely covered by a protective layer commonly known as blood brain barrier (BBB) which is responsible to maintain the homeostasis of brain by restricting the entry of toxic substances, drug molecules, various proteins and peptides, small hydrophilic molecules, large lipophilic substances and so many other peripheral components to protect the brain from any harmful stimuli. This functionally essential structure creates a major hurdle for delivery of any drug into the brain. Still, there are some provisions on BBB which facilitate the entry of useful substances in the brain via specific mechanisms like passive diffusion, receptor-mediated transcytosis, carrier-mediated transcytosis etc. Another important factor for drug transport is the selection of a suitable drug delivery systems like, liposome, which is a novel drug carrier system offering a potential approach to resolving this problem. Its unique phospholipid bilayer structure (similar to physiological membrane) had made it more compatible with the lipoidal layer of BBB and helps the drug to enter the brain. The present review work focused on various surface modifications with functional ligand (like lactoferrin, transferrin etc.) and carrier molecules (such as glutathione, glucose etc.) on the liposomal structure to enhance its brain targeting ability towards the successful treatment of Alzheimer disease.
Keywords: Alzheimer; Glutathione; Lactoferrin; Liposome; Transferrin; β amyloid.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
Multifunctional LUV liposomes decorated for BBB and amyloid targeting - B. In vivo brain targeting potential in wild-type and APP/PS1 mice.Eur J Pharm Sci. 2017 May 1;102:180-187. doi: 10.1016/j.ejps.2017.03.010. Epub 2017 Mar 8. Eur J Pharm Sci. 2017. PMID: 28285172
-
Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease.J Control Release. 2015 Apr 10;203:40-50. doi: 10.1016/j.jconrel.2015.02.012. Epub 2015 Feb 7. J Control Release. 2015. PMID: 25668771
-
In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.Mol Pharm. 2012 Jun 4;9(6):1620-7. doi: 10.1021/mp200621v. Epub 2012 May 7. Mol Pharm. 2012. PMID: 22536790
-
Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood-Brain Barrier Using Receptor-Mediated Transcytosis.Chem Pharm Bull (Tokyo). 2020;68(4):316-325. doi: 10.1248/cpb.c19-00854. Chem Pharm Bull (Tokyo). 2020. PMID: 32238649 Review.
-
Drug delivery strategies with lipid-based nanoparticles for Alzheimer's disease treatment.J Nanobiotechnology. 2025 Feb 10;23(1):99. doi: 10.1186/s12951-025-03109-3. J Nanobiotechnology. 2025. PMID: 39930497 Free PMC article. Review.
Cited by
-
Involvement of Lipids in Alzheimer's Disease Pathology and Potential Therapies.Front Physiol. 2020 Jun 9;11:598. doi: 10.3389/fphys.2020.00598. eCollection 2020. Front Physiol. 2020. PMID: 32581851 Free PMC article. Review.
-
Stealth and Cationic Nanoliposomes as Drug Delivery Systems to Increase Andrographolide BBB Permeability.Pharmaceutics. 2018 Aug 13;10(3):128. doi: 10.3390/pharmaceutics10030128. Pharmaceutics. 2018. PMID: 30104484 Free PMC article.
-
Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties.Int J Nanomedicine. 2019 Aug 14;14:6497-6517. doi: 10.2147/IJN.S215941. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31616141 Free PMC article.
-
Advances in nanotechnology for the treatment of GBM.Front Neurosci. 2023 May 5;17:1180943. doi: 10.3389/fnins.2023.1180943. eCollection 2023. Front Neurosci. 2023. PMID: 37214394 Free PMC article. Review.
-
Innovative Approaches to Enhancing the Biomedical Properties of Liposomes.Pharmaceutics. 2024 Nov 27;16(12):1525. doi: 10.3390/pharmaceutics16121525. Pharmaceutics. 2024. PMID: 39771504 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical